Related Experiment Videos
[Congenital hemolytic anemia].
Bilten Za Hematologiju I Transfuziju
|January 1, 1979
Summary
This study reports on 91 patients with congenital hemolytic anemia (H.a.). Splenectomy is highlighted as a beneficial treatment for H.a. when indicated by radioactive Cr 51 marker tests.
Area of Science:
- Hematology
- Pediatric Medicine
- Medical Diagnostics
Context:
- Congenital hemolytic anemia (H.a.) presents a diagnostic challenge.
- Understanding the etiology and laboratory findings is crucial for patient management.
- Previous studies have explored various treatment modalities for H.a.
Purpose:
- To report on a cohort of 91 patients diagnosed with congenital hemolytic anemia (H.a.).
- To elucidate the causes of congenital H.a. and the laboratory diagnostic methods.
- To emphasize the therapeutic role of splenectomy in select H.a. patients.
Summary:
- The study details 91 cases of congenital hemolytic anemia (H.a.).
- It outlines the underlying causes and laboratory tests aiding diagnosis and subclassification.
- Radioactive chromium-51 (Cr 51) marker tests identified patients who would benefit from splenectomy.
Impact:
- Provides insights into the diagnosis and subclassification of congenital hemolytic anemia.
- Highlights the importance of specific laboratory tests, including Cr 51 imaging, for treatment decisions.
- Demonstrates the therapeutic significance of splenectomy in managing congenital hemolytic anemia.